| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/12/1995 | EP0647231A1 N-substituted 3-azabicyclo 3.2.0]heptane derivates useful as neuroleptic agents, etc. |
| 04/12/1995 | EP0647230A1 Cephalosporins and 1-carba-1-dethia cephalosporins |
| 04/12/1995 | EP0647226A1 9-AMINOPYRIDAZINO 4',5' : 3,4]pyrrolo 2,1-a]ISOQUINOLINES AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS. |
| 04/12/1995 | EP0647222A1 N(hetero)-aryl-n(hetero)-tetralin-alkyl-piperazine having serotoninergic, dopaminergic and adrenergic activity |
| 04/12/1995 | EP0647221A1 1-aryl(4-o-alkoxyphenyl 1-piperazinyl)-2, -3 or -4 alkanols, process for their preparation and use thereof in the preparation of drugs |
| 04/12/1995 | EP0647220A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions |
| 04/12/1995 | EP0647219A1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs. |
| 04/12/1995 | EP0647137A1 Glycine receptor antagonists and the use thereof |
| 04/12/1995 | EP0647136A1 Use of condensed bis-(3,4-dihydro-pyridinyl)methane for treating crohn's disease, colitis ulcerosa, chronic inflamatory processes and as an antiproliferative. |
| 04/12/1995 | EP0647135A1 Bis-(substituted-phenyl) derivatives with cytotoxic and anticancer activity |
| 04/12/1995 | EP0647134A1 Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine |
| 04/12/1995 | EP0647131A1 Dermatological agent for aiding oxygen transport in the skin. |
| 04/12/1995 | EP0609210B1 OPTICALLY ACTIVE 5H-PYRROLO[3,4-b]PYRAZINE DERIVATIVE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT |
| 04/12/1995 | EP0568546B1 Bridged cyclic ketal derivatives |
| 04/12/1995 | EP0539509B1 4-alkylimidazole derivatives |
| 04/12/1995 | EP0527185B1 Amethopterin(methotrexate) pro-drugs, intermediate products, a preparation method, and compositions containing them |
| 04/12/1995 | EP0502042B1 Pharmaceutical compositions |
| 04/12/1995 | EP0487520B1 Compressed powder medicaments |
| 04/12/1995 | EP0428668B1 Water-soluble vitamin a preparations for application to the skin |
| 04/12/1995 | EP0329737B1 Tri-aza macrocycles and metal complexes thereof |
| 04/12/1995 | CN1101349A Novel compounds |
| 04/12/1995 | CN1101348A Method for preparing 1,2-dithiol-3-thion-S-oxid-compound pharmaceutical |
| 04/12/1995 | CN1101347A Process for the manufacture of phenoxyphenoxyalkyl derivatives |
| 04/12/1995 | CN1101346A C2 taxane derivatives and pharmaceutical compositions containing them |
| 04/12/1995 | CN1101260A Material for adjusting function of biology |
| 04/12/1995 | CN1101259A Novel aesculetin derivatives and pharmaceutical |
| 04/12/1995 | CN1101258A Production of composite medicine liq. containing rifamycin antibiotic |
| 04/12/1995 | CN1028174C Process and intermediates for preparing compounds having disubstituted acetylene moiety and retinoic acid-like biological activity |
| 04/12/1995 | CN1028173C Oxazole derivatives |
| 04/12/1995 | CN1028169C Process for direct isolation of captopril |
| 04/12/1995 | CA2133855A1 Heteroarylpiperidines, process for their preparation and pharmaceutical compositions in which they are present |
| 04/11/1995 | US5406014 Dehydrogenation processes, equipment and catalyst loads therefor |
| 04/11/1995 | US5405994 Disodium 4-chlorophenylthiomethylenebisphosphonate monohydrate, its preparation and pharmaceutical compositions in which it is present |
| 04/11/1995 | US5405990 Chemical compounds |
| 04/11/1995 | US5405988 9-substituted bicyclo[3.3.0]octane derivatives, process for their production and their pharmaceutical use |
| 04/11/1995 | US5405966 Trichothecene conjugates |
| 04/11/1995 | US5405964 Imidazopyridines |
| 04/11/1995 | US5405957 Wavelength-specific photosensitive compounds and expanded porphyrin-like compounds and methods of use |
| 04/11/1995 | US5405939 2',5'-phosphorothioate oligoadenylates and their covalent conjugates with polylysine |
| 04/11/1995 | US5405938 Sequence-specific binding polymers for duplex nucleic acids |
| 04/11/1995 | US5405919 Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders |
| 04/11/1995 | US5405875 Method of inhibiting neoplasia and tumor promotion |
| 04/11/1995 | US5405874 Improving short term memory by administering spin-trapping agents such as N-tert-butyl-alpha-phenylnitrone, 5,5-dimethyl-1-pyrroline N-oxide or alpha-/4-pyridyl 1-oxide/-N-tert-butylnitrone |
| 04/11/1995 | US5405872 Anti-hypertensive tetralins |
| 04/11/1995 | US5405868 Treating skin disorders |
| 04/11/1995 | US5405867 Milbemycin derivatives with insecticidal and anthelmintic properties; for plants and animals |
| 04/11/1995 | US5405866 Multidrug resistance modifying dithianes |
| 04/11/1995 | US5405863 Antioxidant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds |
| 04/11/1995 | US5405862 Low free formaldehyde methylolhydantoin compositions |
| 04/11/1995 | US5405861 Triazole compounds and antifungal compositions thereof |
| 04/11/1995 | US5405859 Solvent extraction from plants; fungicides |
| 04/11/1995 | US5405857 3-substituted 1,2,3,4,-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds |
| 04/11/1995 | US5405855 Treatment of insulin resistant diabetes with thalidomine |
| 04/11/1995 | US5405854 Sulfonamidocarboxamides |
| 04/11/1995 | US5405850 Antiviral compositions consisting of acyclovir and a 2-acetyl pyridine derivative |
| 04/11/1995 | US5405849 Treating hypertension, congestive heart failure |
| 04/11/1995 | US5405847 4,5-dihydro-4-oxo-pyrrolo[1,2-a]quinoxalinones and corresponding aza analogs and a process for their preparation |
| 04/11/1995 | US5405846 Mixture of 15-deoxyprostaglandin and adrenergic blocking agent |
| 04/11/1995 | US5405845 (Pyrrolidinyl)phenyl carbamate derivatives and use |
| 04/11/1995 | US5405844 Tetracyclic antibiotics and processes for their preparation |
| 04/11/1995 | US5405842 Steroid-sparing, side effect reduction; sulfasalazine by mouth |
| 04/11/1995 | US5405840 Pranoprofen-containing, suspending medicinal composition |
| 04/11/1995 | US5405838 Topical powder compositions containing a cyclic AMP derivative |
| 04/11/1995 | US5405837 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin |
| 04/11/1995 | US5405742 Contains purge and maintenance solutions; infusing organ to be transplanted with maintenance solution |
| 04/11/1995 | US5405621 Polymer-coated; administering for treatment of digestive disorders |
| 04/11/1995 | US5405620 Pharmaceutical composition for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or tumorous origin |
| 04/11/1995 | US5405619 Controlled release therapeutic system for liquid pharmaceutical formulations |
| 04/11/1995 | US5405598 Sensitizing agents for use in boron neutron capture therapy |
| 04/11/1995 | CA2002300C Compositions for the transdermal delivery of pharmaceutical actives |
| 04/11/1995 | CA1335201C S-adenosyl methionine inhibitors |
| 04/11/1995 | CA1335175C Methods and compositions for the treatment of lung conditions |
| 04/09/1995 | CA2133804A1 1,2-dihydro-2-oxo-3-methylsulfonylaminomethylpyridines |
| 04/08/1995 | CA2133805A1 Composition for prophylaxis and treatment of myopia |
| 04/08/1995 | CA2133706A1 Process for the preparation of pilocarpine derivatives |
| 04/08/1995 | CA2132770A1 Aryl and heterocyclic cyanoguanidine derivatives |
| 04/08/1995 | CA2132766A1 4-arylamino-benzopyran and related compounds |
| 04/06/1995 | WO1995009236A1 USING ANTISENSE OLIGONUCLEOTIDES TO MODULATE NERVE GROWTH AND TO REVERSE β/A4 AMYLOID-INDUCED MORPHOLOGY |
| 04/06/1995 | WO1995009188A1 Antithrombotic |
| 04/06/1995 | WO1995009181A1 Peptide containing amino acid sequence of fimbrial protein of porphyromonas gingivalis and use thereof |
| 04/06/1995 | WO1995009175A1 Ring-expanded nucleosides and nucleotides |
| 04/06/1995 | WO1995009173A1 Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them |
| 04/06/1995 | WO1995009169A1 Process for the preparation of 9-amino camptothecin |
| 04/06/1995 | WO1995009149A1 Anthracene derivatives for use as anticancer agent or dye |
| 04/06/1995 | WO1995009146A1 Parenteral nutrients based on water soluble glycerol bisacetoacetates |
| 04/06/1995 | WO1995009144A1 Nutritive water soluble glycerol esters of hydroxy butyric acid |
| 04/06/1995 | WO1995009011A1 Methods of stimulating phagocytosis |
| 04/06/1995 | WO1995009010A1 Arteriosclerosis remedy |
| 04/06/1995 | WO1995009007A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
| 04/06/1995 | WO1995009006A1 Monoglyceride/lactate ester permeation enhancer |
| 04/06/1995 | WO1995009004A1 Compositions containing growth factors and antiplastic agents |
| 04/06/1995 | WO1995009003A1 Compositions containing growth factors and antimetabolites |
| 04/06/1995 | WO1995009001A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | WO1995009000A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | WO1995008997A1 Ranitidine and calcium carbonate pharmaceutical combination product |
| 04/06/1995 | WO1995008996A1 Method for treatment of eosinophil-associated conditions |
| 04/06/1995 | WO1995008995A1 Antiobestic agent |
| 04/06/1995 | WO1995008994A1 Antineoplastic combination of taxol and tiazofurin |
| 04/06/1995 | WO1995008993A1 Oral formulations of an antifungal |
| 04/06/1995 | WO1995008992A1 Drug for treatment and prophylaxis of bone and joint diseases |